Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • Cross-Sectoral Health Threats
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2024 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. Cross-Sectoral Health Threats
          3. IMEDS
          4. Post Market Research
          5. RAISE
          6. Real World Data
          7. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2024 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

CTP Invites Input on Strategic Plan - Tobacco Reporter

The U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) will hold a virtual listening session on Aug. 22 to give the public an opportunity to comment on its five-year plan it developed to advance its mission.

Coverage
  • Read more about CTP Invites Input on Strategic Plan - Tobacco Reporter

Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation

  • Read more about Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation

Novavax, Inc

By jpalfreyman on Tue, 07/25/2023 - 17:14
  • Read more about Novavax, Inc

FDA Head Robert Califf Battles Misinformation — Sometimes With Fuzzy Facts - Kaiser Health News

Coverage
  • Read more about FDA Head Robert Califf Battles Misinformation — Sometimes With Fuzzy Facts - Kaiser Health News

Biosyngen Pte. Ltd.

By jpalfreyman on Fri, 07/21/2023 - 12:01
  • Read more about Biosyngen Pte. Ltd.

Egetis Therapeutics, Inc.

By jpalfreyman on Fri, 07/21/2023 - 11:23
  • Read more about Egetis Therapeutics, Inc.

PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

  • Read more about PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

An Intermediate Expanded Use Trial of DFMO

  • Read more about An Intermediate Expanded Use Trial of DFMO

FDA Proposes Reorg; Industry Reacts to Impact on Dietary Supplements - Whole Foods Magazine

The U.S. Food and Drug Administration (FDA) recently provided an update on its proposal to create a unified Human Foods Program (HFP). This reorganization includes a new model for the Office of Regulatory Affairs (ORA). 

Read more

Coverage
  • Read more about FDA Proposes Reorg; Industry Reacts to Impact on Dietary Supplements - Whole Foods Magazine

FDA Provides Update on Reagan-Udall Tobacco Panel - Convenience Store Decisions

The administration summarized its progress and next steps following the evaluation from the expert panel regarding the FDA's tobacco program.

Read more

Coverage
  • Read more about FDA Provides Update on Reagan-Udall Tobacco Panel - Convenience Store Decisions

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Current page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA